PERSONAL INFORMATION
ELTON DAJTI, MD
Date of birth: 17.06.1993
Nationality: Albanian
Address: Via Giuseppe Massarenti 9, 40139, Bologna, Italia
E-mail: elton.dajti2@unibo.it [mailto:elton.dajti2@unibo.it] ; e_dajti17@hotmail.com [mailto:e_dajti17@hotmail.com]
Education and training
July 2017: Medical Doctor (MD) Degree summa cum laude, University of Bologna, Italy
June 2019: Basic Ultrasound Diploma, Italian Society for Ultrasound in Medicine and Biology.
November 2021: Certificate for EASL School of Hepatology “Progress, pitfalls, and challenges in the management of portal hypertension”, Barcelona, Spain.
December 2021: Certificate in “Methodology in clinical research”, University of Bologna.
November 2023: Specialist Degree in Gastroenterology summa cum laude, University of Bologna.
March 2023-present: PhD student in “Sciences of General Medicine and Services”, University of Bologna
December 2023: Italian National Academic Qualification as Associate Professor in Gastroenterology.
December 2023-December 2024: Research fellowship in the Hepatology Unit, Inselspital, University Hospital Bern, Switzerland.
Research activity
Research activity in the field of hepatology, liver cirrhosis, portal hypertension, hepatocellular carcinoma, ultrasound and non-invasive tests, rare liver diseases, endoscopy, gastrointestinal oncology.
In particular, current projects focus on non-invasive diagnosis of clinically significant portal hypertension and esophageal varices, non-invasive assessment of response to treatment with non-selective beta-blockers, assessment of portal hypertension in patients with non-alcoholic fatty liver disease, risk stratification for decompensation/recompensation after viral eradication, diagnosis and risk stratification in vascular liver diseases (Budd-Chiari syndrome, porto-sinusoidal vascular disease, liver disease in cystic fibrosis, liver disease in Turner Syndrome, post-chemotherapy liver disease, non-cirrhotic portal vein thrombosis), prognostic role of sarcopenia and malnutrition in patients with compensated and decompensated cirrhosis, impact of portal hypertension on the prognosis of patients with liver cancer.
Coordination of Study Groups
Spleen Stiffness – IPD Study Group, aiming to establish the diagnostic performance of liver and spleen elastography in the diagnosis of clinically significant portal hypertension and esophageal varices through an individual patient data meta-analysis, including more than 20 international centres (PROSPERO: CRD42019127164).
ELASTOVOD Study: prospective, multicentre national study entitled: “Liver Stiffness Measurement Predicts VOD/SOS Development” (ClinicalTrials.gov Identifier: NCT03426358).
Progetto ELASTOSURGERY: prospective, multicentre national study entitled: “Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery”. (ClinicalTrials.gov Identifier: NCT04615091).
Progetto ELASTOMETAVOD: prospective, multicentre, national study, entitled: “Role of non-invasive tests in the prediction of chemotherapy-associated liver injury in patients with hepatic metastases undergoing resection after neoadjuvant chemotherapy.”
Coordination of various National Registries promoted by SIED (Italian Society of Digestive Endoscopy”), among which “BILINCE Study” (Efficacy of ERCP according to ESGE algorithm for papillary cannulation and sphincterotomy), “PROTESIED Study” (National Registry for the use of metallic and plastic stents in patients with malignant biliary obstruction), “STEBINANSIED Study” (“National Registry for the endoscopic treatment of non-anastomotic biliary stenosis in liver transplanted patients”.
Participation in Study Groups
- “ITA.LI.CA” Group: prospective registry of patients with liver cancer in Italy.
- “VALDIG” (Vascular Liver Disease Group).
- “ERN-RARE LIVER”, with a focus on rare liver diseases, including study groups for autoimmune diseases (primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis), vascular disease, liver disease in pregnancy etc.
Bibliometric indicators:
SCOPUS Profile: https://www.scopus.com/authid/detail.uri?authorId=57202136621 )
Study grants
2018-2019: post-graduate study grant at Department of Medical and Surgical Sciences, University of Bologna.
2022-2024: study grant (WFR RC-2022-2773339) for the “ELASTOMETAVOD” project (“Role of non-invasive tests in the prediction of chemotherapy-associated liver injury in patients with hepatic metastases undergoing resection after neoadjuvant chemotherapy.”)
Membership in scientific societies
2019 – present: Italian Association for the Study of the Liver (AISF)
2019 – present: European Association for the Study of the Liver (EASL)
2020 – present: Italian Society of Digestive Endoscopy (SIED)
Contribution to Commissions and Scientific Societies
2020-2022: member of the Scientific Committee of the Italian Society of Digestive Endoscopy. During this period, active participation in promoting several national registries, surveys, and guidelines (“Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)”)
2022-present: Member of the VALDIG Group.
2022-present: Member of the ERN-Liver (Bologna, Full Member). Active participation in the groups on cholestatic diseases, vascular diseases, liver disease in pregnancy.
2023-present: Baveno Cooperation - an EASL Consortium, part of the Communication Committee.
2024: Selected panelist, Baveno VIII Workshop
2024-present: COST-ACTION EURO-VALDI-NET (CA23146). Working group leader “Development of screening tools and diagnostic biomarkers for PSVD”.
Participation in national and international congresses
Oral Presentations
54° ANNUAL MEETING AISF (Rome, March 2022): “Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm”
International Liver Congress 2022 (London, June 2022): “Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm”
FISMAD 2023 (Roma, March 2023): “The prediction of in-hospital mortality and the impact of colonoscopy in patients with acute lower gastrointestinal bleeding: an Italian multicentre study (ALIBY STUDY)
Bologna, 11.09.2023
